CEL Change In Cash vs Ev To Free Cash Flow Analysis
CVM Stock | USD 0.65 0.04 5.80% |
CEL SCI financial indicator trend analysis is way more than just evaluating CEL SCI Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CEL SCI Corp is a good investment. Please check the relationship between CEL SCI Change In Cash and its Ev To Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Change In Cash vs Ev To Free Cash Flow
Change In Cash vs Ev To Free Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CEL SCI Corp Change In Cash account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between CEL SCI's Change In Cash and Ev To Free Cash Flow is -0.45. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of CEL SCI Corp, assuming nothing else is changed. The correlation between historical values of CEL SCI's Change In Cash and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of CEL SCI Corp are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of Change In Cash i.e., CEL SCI's Change In Cash and Ev To Free Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.45 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Change In Cash
Ev To Free Cash Flow
A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.Most indicators from CEL SCI's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CEL SCI Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. As of the 16th of December 2024, Enterprise Value is likely to grow to about 82.9 M, while Selling General Administrative is likely to drop about 5.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 36.1M | 31.5M | 36.2M | 38.0M | Cost Of Revenue | 3.9M | 4.0M | 3.6M | 3.1M |
CEL SCI fundamental ratios Correlations
Click cells to compare fundamentals
CEL SCI Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CEL SCI fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 40.5M | 75.9M | 50.5M | 30.5M | 35.1M | 36.9M | |
Other Current Liab | 102.2K | 863.9K | (417.5K) | 1.6M | 1.8M | 1.8M | |
Total Current Liabilities | 4.3M | 3.9M | 4.7M | 5.6M | 6.4M | 3.6M | |
Total Stockholder Equity | 19.7M | 56.5M | 32.2M | 13.2M | 15.2M | 8.4M | |
Property Plant And Equipment Net | 20.9M | 28.4M | 24.7M | 21.0M | 24.2M | 25.4M | |
Net Debt | (1.6M) | (20.1M) | (7.4M) | 9.4M | 8.5M | 8.9M | |
Retained Earnings | (381.8M) | (418.2M) | (454.9M) | (487.1M) | (438.4M) | (416.5M) | |
Cash | 15.5M | 36.1M | 22.7M | 4.1M | 4.8M | 7.7M | |
Non Current Assets Total | 22.8M | 30.6M | 25.1M | 23.6M | 27.2M | 28.5M | |
Cash And Short Term Investments | 15.5M | 42.2M | 22.7M | 4.1M | 4.8M | 8.1M | |
Common Stock Shares Outstanding | 36.8M | 40.7M | 43.1M | 44.5M | 51.2M | 53.7M | |
Liabilities And Stockholders Equity | 40.5M | 75.9M | 50.5M | 30.5M | 35.1M | 36.9M | |
Other Current Assets | 1.3M | 998.5K | 762.1K | 524.6K | 472.2K | 448.5K | |
Other Stockholder Equity | 401.2M | 474.3M | 486.6M | 499.8M | 574.8M | 603.5M | |
Total Liab | 20.8M | 19.3M | 18.4M | 17.3M | 19.9M | 20.9M | |
Property Plant And Equipment Gross | 5.8M | 32.5M | 30.6M | 29.0M | 33.3M | 35.0M | |
Total Current Assets | 17.7M | 45.3M | 25.4M | 6.9M | 8.0M | 9.9M | |
Non Current Liabilities Total | 16.5M | 15.4M | 13.7M | 11.7M | 13.5M | 14.2M | |
Short Long Term Debt Total | 13.9M | 16.0M | 15.3M | 13.6M | 15.6M | 16.4M | |
Short Term Debt | 2.1M | 1.4M | 3.5M | 2.0M | 2.3M | 1.2M | |
Intangible Assets | 313.4K | 275.9K | 212.2K | 197.7K | 177.9K | 284.1K | |
Accounts Payable | 2.0M | 1.7M | 1.6M | 2.0M | 2.3M | 1.4M | |
Net Receivables | 118.7K | 62.8K | 54.9K | (2.0M) | (1.8M) | (1.7M) | |
Common Stock Total Equity | 352.3K | 387.3K | 432.1K | 434.5K | 499.7K | 959.4K | |
Common Stock | 387.3K | 432.1K | 434.5K | 474.2K | 426.8K | 682.4K | |
Other Liab | 7.0M | 6.0M | 3.7M | 125K | 143.8K | 136.6K | |
Property Plant Equipment | 15.8M | 5.8M | 13.7M | 12.1M | 13.9M | 14.6M | |
Inventory | 820.1K | 2.0M | 2.0M | 2.2M | 2.6M | 2.7M | |
Net Tangible Assets | 5.1M | 19.4M | 56.3M | 32.0M | 36.7M | 38.6M | |
Retained Earnings Total Equity | (353.7M) | (381.8M) | (418.2M) | (454.9M) | (409.4M) | (429.9M) | |
Capital Surpluse | 358.5M | 401.2M | 474.3M | 486.6M | 559.6M | 351.9M | |
Non Current Liabilities Other | 13.5M | 13.0M | 125K | 13.7M | 143.8K | 136.6K | |
Long Term Debt Total | 13.5M | 11.8M | 13.3M | 11.7M | 13.5M | 12.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.61) | Return On Equity (2.50) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.